Nuveen Asset Management’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-184,772
| Closed | -$1.02M | – | 3494 |
|
|
2022
Q1 | $1.02M | Buy |
184,772
+10,122
| +6% | +$56.1K | ﹤0.01% | 2814 |
|
|
2021
Q4 | $1.69M | Buy |
174,650
+29,924
| +21% | +$290K | ﹤0.01% | 2646 |
|
|
2021
Q3 | $3.02M | Sell |
144,726
-3,066
| -2% | -$64.1K | ﹤0.01% | 2479 |
|
|
2021
Q2 | $3.61M | Sell |
147,792
-11,701
| -7% | -$286K | ﹤0.01% | 2409 |
|
|
2021
Q1 | $4.23M | Sell |
159,493
-18,979
| -11% | -$503K | ﹤0.01% | 2242 |
|
|
2020
Q4 | $1.35M | Sell |
178,472
-745
| -0.4% | -$5.65K | ﹤0.01% | 2692 |
|
|
2020
Q3 | $897K | Buy |
179,217
+38,971
| +28% | +$195K | ﹤0.01% | 2731 |
|
|
2020
Q2 | $839K | Sell |
140,246
-55,955
| -29% | -$335K | ﹤0.01% | 2696 |
|
|
2020
Q1 | $873K | Buy |
196,201
+1,142
| +0.6% | +$5.08K | ﹤0.01% | 2567 |
|
|
2019
Q4 | $1.85M | Buy |
195,059
+62,721
| +47% | +$596K | ﹤0.01% | 2448 |
|
|
2019
Q3 | $1.04M | Buy |
132,338
+7,156
| +6% | +$56.2K | ﹤0.01% | 2693 |
|
|
2019
Q2 | $1.97M | Buy |
+125,182
| New | +$1.97M | ﹤0.01% | 2444 |
|